These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 35110645)

  • 1. Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).
    Jeewandara C; Fernando S; Pushpakumara PD; Ramu ST; Kamaladasa A; Gunasekara B; Aberathna IS; Kuruppu H; Ranasinghe T; Dayarathne S; Dissanayake O; Gamalath N; Ekanayake D; Jayamali J; Wijesinghe A; Dissanayake M; Somathilake G; Harvie M; Danasekara S; Jayathilaka D; Wijayatilake HDK; Weerasooriya N; Kekulandara C; Schimanski L; Rijal P; Tan TK; Dong T; Townsend A; Ogg GS; Malavige GN
    Sci Rep; 2022 Feb; 12(1):1727. PubMed ID: 35110645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of BNT162b2, BBIBP-CorV and Gam-COVID-Vac vaccines and immunity after natural SARS-CoV-2 infection-A comparative study from Novi Sad, Serbia.
    Petrović V; Vuković V; Patić A; Marković M; Ristić M
    PLoS One; 2022; 17(2):e0263468. PubMed ID: 35108321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?
    Terpos E; Trougakos IP; Karalis V; Ntanasis-Stathopoulos I; Sklirou AD; Bagratuni T; Papanagnou ED; Patseas D; Gumeni S; Malandrakis P; Korompoki E; Dimopoulos MA
    Am J Hematol; 2021 Sep; 96(9):E321-E324. PubMed ID: 34028867
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct comparison of antibody responses to four SARS-CoV-2 vaccines in Mongolia.
    Dashdorj NJ; Wirz OF; Röltgen K; Haraguchi E; Buzzanco AS; Sibai M; Wang H; Miller JA; Solis D; Sahoo MK; Arunachalam PS; Lee AS; Shah MM; Liu J; Byambabaatar S; Bat-Ulzii P; Enkhbat A; Batbold E; Zulkhuu D; Ochirsum B; Khurelsukh T; Dalantai G; Burged N; Baatarsuren U; Ariungerel N; Oidovsambuu O; Bungert AS; Genden Z; Yagaanbuyant D; Mordorj A; Pulendran B; Chinthrajah S; Nadeau KC; Jardetzky T; Wilbur JL; Wohlstadter JN; Sigal GB; Pinsky BA; Boyd SD; Dashdorj ND
    Cell Host Microbe; 2021 Dec; 29(12):1738-1743.e4. PubMed ID: 34861167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.
    Jeewandara C; Kamaladasa A; Pushpakumara PD; Jayathilaka D; Aberathna IS; Danasekara DRSR; Guruge D; Ranasinghe T; Dayarathna S; Pathmanathan T; Somathilake G; Deshan Madhusanka PA; Ramu ST; Pramanayagam Jayadas TT; Kuruppu H; Wijesinghe A; Thashmi Nimasha HM; Milroy D; Nandasena AA; Nilanka Sanjeewani PKG; Wijayamuni R; Samaraweera S; Schimanski L; Tan TK; Dong T; Ogg GS; Townsend A; Malavige GN
    Nat Commun; 2021 Jul; 12(1):4617. PubMed ID: 34326317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans.
    Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM
    Front Immunol; 2021; 12():728021. PubMed ID: 34646267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
    Fendler A; Shepherd STC; Au L; Wilkinson KA; Wu M; Byrne F; Cerrone M; Schmitt AM; Joharatnam-Hogan N; Shum B; Tippu Z; Rzeniewicz K; Boos LA; Harvey R; Carlyle E; Edmonds K; Del Rosario L; Sarker S; Lingard K; Mangwende M; Holt L; Ahmod H; Korteweg J; Foley T; Bazin J; Gordon W; Barber T; Emslie-Henry A; Xie W; Gerard CL; Deng D; Wall EC; Agua-Doce A; Namjou S; Caidan S; Gavrielides M; MacRae JI; Kelly G; Peat K; Kelly D; Murra A; Kelly K; O'Flaherty M; Dowdie L; Ash N; Gronthoud F; Shea RL; Gardner G; Murray D; Kinnaird F; Cui W; Pascual J; Rodney S; Mencel J; Curtis O; Stephenson C; Robinson A; Oza B; Farag S; Leslie I; Rogiers A; Iyengar S; Ethell M; Messiou C; Cunningham D; Chau I; Starling N; Turner N; Welsh L; van As N; Jones RL; Droney J; Banerjee S; Tatham KC; O'Brien M; Harrington K; Bhide S; Okines A; Reid A; Young K; Furness AJS; Pickering L; Swanton C; ; Gandhi S; Gamblin S; Bauer DLV; Kassiotis G; Kumar S; Yousaf N; Jhanji S; Nicholson E; Howell M; Walker S; Wilkinson RJ; Larkin J; Turajlic S;
    Nat Cancer; 2021 Dec; 2(12):1305-1320. PubMed ID: 35121899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
    Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
    Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
    Fendler A; Shepherd STC; Au L; Wilkinson KA; Wu M; Byrne F; Cerrone M; Schmitt AM; Joharatnam-Hogan N; Shum B; Tippu Z; Rzeniewicz K; Boos LA; Harvey R; Carlyle E; Edmonds K; Del Rosario L; Sarker S; Lingard K; Mangwende M; Holt L; Ahmod H; Korteweg J; Foley T; Bazin J; Gordon W; Barber T; Emslie-Henry A; Xie W; Gerard CL; Deng D; Wall EC; Agua-Doce A; Namjou S; Caidan S; Gavrielides M; MacRae JI; Kelly G; Peat K; Kelly D; Murra A; Kelly K; O'Flaherty M; Dowdie L; Ash N; Gronthoud F; Shea RL; Gardner G; Murray D; Kinnaird F; Cui W; Pascual J; Rodney S; Mencel J; Curtis O; Stephenson C; Robinson A; Oza B; Farag S; Leslie I; Rogiers A; Iyengar S; Ethell M; Messiou C; Cunningham D; Chau I; Starling N; Turner N; Welsh L; van As N; Jones RL; Droney J; Banerjee S; Tatham KC; O'Brien M; Harrington K; Bhide S; Okines A; Reid A; Young K; Furness AJS; Pickering L; Swanton C; ; Gandhi S; Gamblin S; Bauer DL; Kassiotis G; Kumar S; Yousaf N; Jhanji S; Nicholson E; Howell M; Walker S; Wilkinson RJ; Larkin J; Turajlic S
    Nat Cancer; 2021 Dec; 2():1321-1337. PubMed ID: 34950880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
    Jeewandara C; Guruge D; Pushpakumara PD; Kamaladasa A; Aberathna IS; Ramu ST; Gunasekera B; Wijesinghe A; Dissanayake O; Kuruppu H; Ranasinghe T; Jayathilaka D; Dayarathna S; Ekanayake D; Jayamali J; Gamalath N; Mudunkotiwa A; Somathilake G; Dissanayake M; Harvie M; Nimasha T; Madusanka D; Jayadas T; Wijayamuni R; Schimanski L; Rijal P; Tan TK; Townsend A; Ogg GS; Malavige GN
    J Immunol; 2021 Dec; 207(11):2681-2687. PubMed ID: 34750205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group.
    Escobar A; Reyes-López FE; Acevedo ML; Alonso-Palomares L; Valiente-Echeverría F; Soto-Rifo R; Portillo H; Gatica J; Flores I; Nova-Lamperti E; Barrera-Avalos C; Bono MR; Vargas L; Simon V; Leiva-Salcedo E; Vial C; Hormazabal J; Cortes LJ; Valdés D; Sandino AM; Imarai M; Acuña-Castillo C
    Front Immunol; 2021; 12():766278. PubMed ID: 35173705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial.
    Wu S; Huang J; Zhang Z; Wu J; Zhang J; Hu H; Zhu T; Zhang J; Luo L; Fan P; Wang B; Chen C; Chen Y; Song X; Wang Y; Si W; Sun T; Wang X; Hou L; Chen W
    Lancet Infect Dis; 2021 Dec; 21(12):1654-1664. PubMed ID: 34324836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of immune activation of the COVID vaccines: ChAdOx1, BNT162b2, mRNA-1273, BBIBP-CorV, and Gam-COVID-Vac from serological human samples in Hungary showed higher protection after mRNA-based immunization.
    Fodor E; Olmos Calvo I; Kuten-Pella O; Hamar E; Bukva M; Madár Á; Hornyák I; Hinsenkamp A; Hetényi R; Földes F; Brigitta Z; Jakab F; Kemenesi G; Lacza Z
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(14):5297-5306. PubMed ID: 35916830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Voysey M; Costa Clemens SA; Madhi SA; Weckx LY; Folegatti PM; Aley PK; Angus B; Baillie VL; Barnabas SL; Bhorat QE; Bibi S; Briner C; Cicconi P; Clutterbuck EA; Collins AM; Cutland CL; Darton TC; Dheda K; Dold C; Duncan CJA; Emary KRW; Ewer KJ; Flaxman A; Fairlie L; Faust SN; Feng S; Ferreira DM; Finn A; Galiza E; Goodman AL; Green CM; Green CA; Greenland M; Hill C; Hill HC; Hirsch I; Izu A; Jenkin D; Joe CCD; Kerridge S; Koen A; Kwatra G; Lazarus R; Libri V; Lillie PJ; Marchevsky NG; Marshall RP; Mendes AVA; Milan EP; Minassian AM; McGregor A; Mujadidi YF; Nana A; Padayachee SD; Phillips DJ; Pittella A; Plested E; Pollock KM; Ramasamy MN; Ritchie AJ; Robinson H; Schwarzbold AV; Smith A; Song R; Snape MD; Sprinz E; Sutherland RK; Thomson EC; Török ME; Toshner M; Turner DPJ; Vekemans J; Villafana TL; White T; Williams CJ; Douglas AD; Hill AVS; Lambe T; Gilbert SC; Pollard AJ;
    Lancet; 2021 Mar; 397(10277):881-891. PubMed ID: 33617777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.
    Melo-González F; Soto JA; González LA; Fernández J; Duarte LF; Schultz BM; Gálvez NMS; Pacheco GA; Ríos M; Vázquez Y; Rivera-Pérez D; Moreno-Tapia D; Iturriaga C; Vallejos OP; Berríos-Rojas RV; Hoppe-Elsholz G; Urzúa M; Bruneau N; Fasce RA; Mora J; Grifoni A; Sette A; Weiskopf D; Zeng G; Meng W; González-Aramundiz JV; González PA; Abarca K; Ramírez E; Kalergis AM; Bueno SM
    Front Immunol; 2021; 12():747830. PubMed ID: 34858404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice.
    de Alwis R; Gan ES; Chen S; Leong YS; Tan HC; Zhang SL; Yau C; Low JGH; Kalimuddin S; Matsuda D; Allen EC; Hartman P; Park KJ; Alayyoubi M; Bhaskaran H; Dukanovic A; Bao Y; Clemente B; Vega J; Roberts S; Gonzalez JA; Sablad M; Yelin R; Taylor W; Tachikawa K; Parker S; Karmali P; Davis J; Sullivan BM; Sullivan SM; Hughes SG; Chivukula P; Ooi EE
    Mol Ther; 2021 Jun; 29(6):1970-1983. PubMed ID: 33823303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon
    Byazrova MG; Kulemzin SV; Astakhova EA; Belovezhets TN; Efimov GA; Chikaev AN; Kolotygin IO; Gorchakov AA; Taranin AV; Filatov AV
    Front Immunol; 2022; 13():840707. PubMed ID: 35280987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.
    Jeewandara C; Aberathna IS; Danasekara S; Gomes L; Fernando S; Guruge D; Ranasinghe T; Gunasekera B; Kamaladasa A; Kuruppu H; Somathilake G; Jayamali J; Jayathilaka D; Wijayatilake HDK; Pushpakumara PD; Harvie M; Nimasha T; de Silva SDG; Wijayamuni R; Schimanski L; Rijal P; Tan J; Townsend A; Ogg GS; Malavige GN
    Immunology; 2022 Oct; 167(2):263-274. PubMed ID: 35751563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of immunization time, amplitude, and adverse events of seven different vaccines against SARS-CoV-2 across four different countries.
    Romero-Ibarguengoitia ME; González-Cantú A; Pozzi C; Levi R; Mollura M; Sarti R; Sanz-Sánchez MÁ; Rivera-Salinas D; Hernández-Ruíz YG; Armendariz-Vázquez AG; Del Rio-Parra GF; Barco-Flores IA; González-Facio R; Azzolini E; Barbieri R; de Azevedo Dias AR; Henriques Guimarães Júnior M; Bastos-Borges A; Acciardi C; Paez-Bo G; Teixeira MM; Rescigno M
    Front Immunol; 2022; 13():894277. PubMed ID: 35967368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.